Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-93,800
Closed -$1.17M 4655
2025
Q3
$1.17M Buy
+93,800
New +$961K ﹤0.01% 3362
2024
Q4
Sell
-17,100
Closed -$53.9K 4469
2024
Q3
$53.9K Sell
17,100
-2,700
-14% -$7.94K ﹤0.01% 4295
2024
Q2
$56K Buy
+19,800
New +$141K ﹤0.01% 4209
2021
Q3
Sell
-10,000
Closed -$1.07M 5002
2021
Q2
$1.07M Sell
10,000
-8,000
-44% -$787K ﹤0.01% 3477
2021
Q1
$1.61M Buy
18,000
+10,000
+125% +$1.1M ﹤0.01% 2769
2020
Q4
$804K Sell
8,000
-26,900
-77% -$2.01M ﹤0.01% 3166
2020
Q3
$1.71M Buy
+34,900
New +$1.68M ﹤0.01% 2508

Other funds holding CRNC

David Shaw's CRNC Position: Q2 2026 in Review

David Shaw reduced its Cerence (CRNC) stake by 40% in Q2 2026, selling an estimated $1.38M and leaving 214,328 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #3041.

David Shaw first reported a position in CRNC in Q4 2019 and has held it in 22 quarters since. The position peaked at $14.6M in Q4 2024. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • David Shaw held 214,328 shares of Cerence worth $2.43M as of Q2 2026.
  • David Shaw sold 140,850 Cerence shares in Q2 2026, an estimated $1.38M.
  • Cerence made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3041 holding.
  • David Shaw first reported a position in Cerence in Q4 2019 and has held it in 22 quarters since.
  • David Shaw's Cerence position peaked at $14.6M in Q4 2024.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.